Are These Penny Stocks On Your List To Buy Or Sell Before The Holiday?
We’ve said it in the past, just because something’s low-priced, doesn’t mean it’s good to buy. However, when you talk about penny stocks, the word “cheap” can be a big plus. Now, if you’re new to trading penny stocks you may not know what they are. But it’s really simple. According to the Securities and Exchange Commission, penny stocks are shares of companies trading below $5 a share. Now that we’ve established that, let’s look at ways to make money with penny stocks.
How To Make Money With Penny Stocks
It really doesn’t matter if it’s high or low-priced penny stocks, traders look at specific things before they buy. First, if you’re “trading penny stocks” then momentum will play a big role. Liquidity is what allows you to enter and exit trades easier and at optimal price levels.
If you find penny stocks you like because of the business models but they don’t have higher volume, it’s going to be tough for you to buy and sell at optimal prices. Next, catalysts are something people look for. This can come from penny stock news, filings, rumors, or even oversight agencies like the FDA or USPTO.
- Penny Stocks Trading for Beginners 
- EV Penny Stocks Charge Up In July 2020 After Record Deliveries
- Did These Low Float Penny Stocks Make The Cut This Week?
Finally, day traders will look at chart patterns. While they aren’t infallible, there’s something to be said about certain chart patterns and their ability to indicate a higher rate of bullish or bearish momentum. Needless to say, it’s never a bad idea to have a plan in place to trade with. Right now, these 4 stocks are trading below $3.50. Will they be the best penny stocks to buy in July?
Penny Stocks to Buy For Under $3.50: Genius Brands
As our readers know, Genius Brands (GNUS Stock Report) has been one of the volatile penny stocks to watch this year. To think that it was trading below $1 a share at one point is almost unthinkable. But when we first started following its developments, GNUS stock was trading around $0.36. Since then, many have watched as this company reached new milestones and climbed to highs of $11.73 at the start of June. A series of events eventually resulted in shares “coming back to earth” later in the month. However, GNUS stock continued maintaining levels of support much higher than where it traded in April.
The biggest focus for the company is getting its shows into prime distribution. Most recently, John Landis, legendary multi-award-winning director and producer, came on the production team. Landis will direct Arnold Schwarzenegger, who lends his voice to the starring role of the action-adventure comedy series co-created by Stan Lee, Stan Lee’s Superhero Kindergarten. Landis has also joined Genius Brands’ development team to help create a live-action series and feature film spin-off as well.
This month started off on a bright note. The company announced a bizdev call will be held next week to go over all recent developments. While there weren’t many other details, this seems to have gotten the market excited again. The call will happen during market hours on July 6 at 10 AM EST.
Penny Stocks To Buy For Under $3.50: MannKind Corporation
Shares of MannKind Corp. (MNKD Stock Report) were on the move Thursday morning. In our last update on the company we discussed that new data from clinical studies of its Afrezza® Inhalation Powder were presented at the American Diabetes Association’s 80th Scientific Sessions. Of note, an analysis demonstrated treatment with Afrezza is associated with weight loss in patients with type 2 diabetes. This is compared to weight gain with injected mealtime insulin.
At the recent Lytham Partners Virtual Investor Growth Conference, MannKind CEO Michael Castagna gave an overview of the company. He also discussed plans moving forward. One of the key points of focus was on BluHale, its connected technology. Castagna said, “So, we’re looking to move into connected care and virtual trainings. BluHale is a great way to help train patients and also for doctors to start to see dosing,” he continued, “BluHale…is something that allows us to teach patients visually and see how they’re inhaling properly and how much effort is required. So, all this goes into connected care in the future and that’s what we’re excited about.”
The comapny plans to launch BluHale PRO in July. What’s more is that MannKind expects to get it to its salesforce & customers in August. As we’ve come to know since September of last year, MNKD stock can be volatile. However, overall, shares have continued to climb and are up more than 30% to date. Will the new focus on BluHale help breath some fresh momentum into the market for MNKD?
Penny Stocks To Buy For Under $3.50: Shiloh Industries Inc.
Shiloh Industries Inc. (SHLO Stock Report) is somewhat of an anomaly right now. We discussed this company a few days ago as the stock saw its first unusual volume spike. Shares jumped from around $1 to highs of $1.80. Since then the penny stock has held levels near those highs. But one thing that hasn’t been present is information. The last piece of news that came from the company was regarding amendments to bank loans and it would resume global operations.
One thing that could have had an impact was the recent trend in EV stocks. In the company’s corporate overview, it discusses the use of its components in electric vehicles. Specifically, “Shiloh lightweight products enable range expansion by reducing power consumption [and are] propulsion agnostic (EV, HEV and ICE).” But aside from this piece of info, Shiloh, on a higher-level view, has focused on renewable energy use at its actual facilities. The company has set the goal of carbon neutrality by 2035.
The lack of info hasn’t slowed down trading momentum, however. July 2 saw continued levels of above average trading volume. Shares of SHLO stock broke above $1.60 for the third day in a row. So, it will be interesting to see if there’s a story to unfold in July or if this is simply a sympathy move from a surge in EV stocks.
Penny Stocks To Buy For Under $3.50: Ampio Pharmaceuticals Inc.
Ampio Pharmaceuticals Inc. (AMPE Stock Report) headed higher in July. The company focuses primarily on developing compounds that decrease inflammation. If you remember from our first few articles in April, AMPE stock was on the watch list. This was just after the company was preparing an expanded access FDA protocol. This was to study the possible benefits of its Ampion treatment via nebulizer to targeting Acute Respiratory Distress Syndrome induced by coronavirus. Further to this, more progress came in May.
A manuscript accepted for publication in The Journal of Patient Safety in Surgery showed that Ampion treatment could improve clinical outcomes for COVID-19 patients. Ampio then filed an IND application for Ampion with the FDA about a week and a half later. From there, the FDA gave clearance to formally begin trials for human testing of its investigational COVID-19 treatment.
This week, there hasn’t been any news released. However, as I said above, sometimes it’s about looking beyond the company’s own headlines. Case in point, shares ticked higher following a posting on ClinicalTrials . gov showing that trials had started. According to the post, the estimated study completion date is in early November with a primary completion date coming in early August.
The penny stock reached early highs of $0.7374 on July 2. After that, AMPE stock has traded relatively sideways for most of the Thursday session.